Earlier this week, the Pink Sheet offered some historical context around the 60 novel agents approved by the US Food and Drug Administration in 2021, the second biggest total in contemporary agency history. (Also see "US FDA Novel Approvals Grew To 60 In 2021; CDER Cleared 50 New Agents, Turned Down 18" - Pink Sheet, 2 January, 2022.)
Below, we offer a look at how those products got across the finish line, from the expediting designations they received...






